In Billing
Jun 1st, 2012
Effective May 14, TrailBlazer Health Enterprises has instituted an edit for the following laboratory CPT® codes: 80074 Acute hepatitis panel 80076 Hepatic function panel These lab services have been identified by the Part A/B Medicare administrative contractor (MAC) as having a high error rate through Comprehensive Error Rate Testing (CERT). “These services are frequently denied due ...
May 1st, 2012
Place of service errors are on the OIG hit list, so be sure your coding is up to par. By G.J. Verhovshek, MA, CPC For the third consecutive year, the U.S. Department of Health & Human Services (HHS) Office of Inspector General (OIG) has included place-of-service (POS) errors as an area for review in its ...
In Billing
Mar 2nd, 2012
If you commonly report CPT® 11980 Subcutaneous hormonal pellet implantation beneath the skin along with either HCPCS Level II code S0189 Testosterone pellet, 75 mg or J3490 Unclassified drug, you may want to check with your payer to make sure your claims will be paid. TrailBlazer Health Enterprises, Medicare administrative contractor for jurisdiction 4 (J4-MAC), ...
In Coding
Mar 2nd, 2012
For the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy, you would be correct to report HCPCS Level II code Q2044 Injection, belimumab, 10 mg for dates of service July 1, 2011 through Dec. 31, 2011. For 2012, however, at least one Medicare administrative contractor (MAC) has indicated ...
In Billing
Dec 30th, 2011
Beginning Jan. 1, 2012, a new HCPCS Level II code has been assigned to the drug denosumab. Formally C9272 Injection, denosumab, 1 mg, denosumab should now be reported with J0897 (description remains the same). The drug denosumab has two brand names with two different indications: Prolia® – indicated to treat osteoporosis in women after menopause. Xgeva® – ...